Literature DB >> 2028777

Topical indomethacin for vernal keratoconjunctivitis.

S Gupta1, A K Khurana, B K Ahluwalia, N C Gupta.   

Abstract

Twenty-five patients with vernal keratoconjunctivitis (VKC) were treated with 1% indomethacin eyedrops and were followed for 5 weeks. Apart from 4 patients all of them showed marked improvement. The possible mechanism of the role of indomethacin in VKC is discussed.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2028777     DOI： 10.1111/j.1755-3768.1991.tb02000.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN： 0001-639X


  5 in total

1.  Bromfenac ophthalmic solution 0.09 %: human aqueous humor concentration detected by high-performance liquid chromatography.

Authors:  Angelo Macrì; Aldo Vagge; Annalisa Salis; Carmen Fucile; Valeria Marini; Antonietta Martelli; Sebastiano Giuffrida; Michele Iester; Gianluca Damonte; Francesca Mattioli
Journal:  Int Ophthalmol       Date:  2016-06-20       Impact factor: 2.031

Review 2.  An Update on the Therapeutic Approach to Vernal Keratoconjunctivitis.

Authors:  Susanna Esposito; Giulia Fior; Alessandro Mori; Silvia Osnaghi; Daniele Ghiglioni
Journal:  Paediatr Drugs       Date:  2016-10       Impact factor: 3.022

3.  Levels of prostaglandin E2 and leukotriene B4 in tears of vernal conjunctivitis patients during a therapeutic trial with indomethacin.

Authors:  H Nathan; N Naveh; E Meyer
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

4.  Corneal sensitivity after topical bromfenac sodium eye-drop instillation.

Authors:  Kaori Yanai; Jane Huang; Kazuaki Kadonosono; Eiichi Uchio
Journal:  Clin Ophthalmol       Date:  2013-04-17

5.  Management of vernal keratoconjunctivitis.

Authors:  Andrea Leonardi
Journal:  Ophthalmol Ther       Date:  2013-09-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.